Barbara Bortle-gainey is a pharmacist who is specialized in Oncology in Brooklyn, New York. Patients can reach her at 150 55th St, Brooklyn or contact her on 718-630-7050. Active license number of Barbara Bortle-gainey is 036685 for Oncology in New York. Barbara Bortle-gainey is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Barbara Bortle-gainey speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Barbara Bortle-gainey
Specialization:
Oncology
Credentials:
RPH
Gender:
Female
Location:
150 55th St, Brooklyn, New York, 11220-2508
Phone:
718-630-7050
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Barbara Bortle-gainey are as mentioned below.
NPI Number:
1003296583
NPI Enumeration Date:
01 Jun, 2015
NPI Last Update On:
01 Jun, 2015
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Barbara Bortle-gainey are as mentioned below.
Specialization
License Number
State
Status
Oncology
036685
New York
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
27 Pierpont Pl, Staten Island, New York
Zip:
10314-5946
Phone Number:
646-637-8137
Fax Number:
--
Patients can reach Barbara Bortle-gainey at 150 55th St, Brooklyn, New York or can call on phone at 718-630-7050.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.